Liver cancer surveillance among high-risk individuals usually leads to earlier diagnoses and improved survival rates among patients. However, this requires several steps, including identification of high-risk patients, compliance with surveillance recommendations, and highly accurate and accessible imaging tools.
The University of Michigan Rogel Cancer Center has named Andrzej Dlugosz, M.D., associate director for basic science research. He currently co-leads the Rogel Cancer Center’s cancer biology program. In his new role, Dlugosz will oversee the Rogel Cancer Center’s four basic science research programs.
A team at the University of Michigan Rogel Cancer Center recently sought to determine how much newly diagnosed cancer patients understand about the benefits of genetic testing after a diagnosis. Their other objective: to find out whether a decision support tool would help improve that knowledge.
Radiation therapy outcomes better for African-American prostate cancer patients than Caucasian patients
While popular beliefs and population data suggest that African-American men are at higher risk of dying from prostate cancer than Caucasian men, a new analysis indicates that African-American patients may have comparatively higher cure rates when treated with radiation therapy.
Researchers from the University of Michigan Rogel Cancer Center will attend the American Society for Radiation Oncology (ASTRO) Annual meeting from Sunday, October 21 through Wednesday, October 24. Many of them plan to participate in poster sessions and oral presentations. A schedule is available to make it easy to know who is presenting, when, where and on what topic
Lori J. Pierce, M.D., is among the new members of the National Academy of Medicine of the National Academies, one of the highest honors in the fields of health and medicine. The institute was formerly called the Institute of Medicine.
The University of Michigan Rogel Cancer Center and Aetna announced a collaboration to create an oncology medical home that is designed to improve the care experience for cancer patients. This approach encourages teams of cancer specialists to work together to care for a patient with a cancer diagnosis.
Smoking-related lung cancer rates are expected to drop dramatically over the next 50 years, but lung cancer will continue to be a significant health problem in the United States, says a University of Michigan researcher.
University of Michigan School of Nursing professor and Rogel Cancer Center member, Christopher Friese has been appointed a member of the Governing Board of the Patient-Centered Outcomes Research Institution, part of the US Government Accountability Office.
The University of Michigan School of Public Health will house a new, multi-institutional center focusing on modeling and predicting the impact of tobacco regulation, funded with an $18 million federal grant from the National Institutes of Health and the Food and Drug Administration.